The death of former U.S. Rep. Mia Love has brought renewed attention to an aggressive form of brain cancer that killed her at ...

The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma.

Researchers at The University of Texas Health Science Center at San Antonio have discovered a way to delay or even block ...

Early results show that the combination of VXM01 plus avelumab demonstrated tolerable safety in recurrent glioblastoma.

Treatment with VXM01, an investigational vaccine, plus Bavencio demonstrated both safety and tolerability in patients with ...

Glioblastoma, one of the most aggressive and lethal brain cancers, has a five-year survival rate of only 6.9%, according to the National Brain Tumor Society. While the relationship between ...

What is glioblastoma, the aggressive brain cancer that killed Mia Love at 49? - The death of former U.S. Rep. Mia Love has ...

Former Utah Rep. Mia Love's death is bringing glioblastoma, an aggressive and rapidly growing form of brain cancer, into focus. According to the M.D. Anderson Cancer Center at the University of Texas, ...